S. Holmäng

661 total citations
17 papers, 500 citations indexed

About

S. Holmäng is a scholar working on Surgery, Urology and Oncology. According to data from OpenAlex, S. Holmäng has authored 17 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 3 papers in Urology and 3 papers in Oncology. Recurrent topics in S. Holmäng's work include Bladder and Urothelial Cancer Treatments (16 papers), Urinary and Genital Oncology Studies (12 papers) and Urological Disorders and Treatments (2 papers). S. Holmäng is often cited by papers focused on Bladder and Urothelial Cancer Treatments (16 papers), Urinary and Genital Oncology Studies (12 papers) and Urological Disorders and Treatments (2 papers). S. Holmäng collaborates with scholars based in Sweden, United States and Canada. S. Holmäng's co-authors include Sonny L. Johansson, Göran Borghede, Luis A. Kluth, Pierre I. Karakiewicz, Shahrokh F. Shariat, Evi Comploj, Yair Lotan, A. Pycha, Douglas S. Scherr and Andrew J. Vickers and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and British Journal of Cancer.

In The Last Decade

S. Holmäng

15 papers receiving 484 citations

Peers

S. Holmäng

SURGE

UROLO

ONCOL

PRM

G. Zampa Italy

Gary Bokinsky United States

Óscar Rodríguez Spain

A. Unal Türkiye

Soloway Ms United States

A P van der Meijden Netherlands

Amiel E. Gilad Israel

Ulrich Gertenbach Germany

Agostino Meneghini Italy

N.M. Heney United States

G. Zampa Italy

S. Holmäng

223 ×0.5

SURGE

104 ×0.9

UROLO

110 ×1.1

ONCOL

39 ×0.5

PRM

49 ×1.2

Citations per year, relative to S. Holmäng S. Holmäng (= 1×) peers G. Zampa

Countries citing papers authored by S. Holmäng

Since Specialization

Citations

This map shows the geographic impact of S. Holmäng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Holmäng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Holmäng more than expected).

Fields of papers citing papers by S. Holmäng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Holmäng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Holmäng. The network helps show where S. Holmäng may publish in the future.

Co-authorship network of co-authors of S. Holmäng

This figure shows the co-authorship network connecting the top 25 collaborators of S. Holmäng. A scholar is included among the top collaborators of S. Holmäng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Holmäng. S. Holmäng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Sylvester, Richard, W. Oosterlinck, S. Holmäng, et al.. (2015). 939 Systematic review and individual patient data meta-analysis of randomized trials comparing a single immediate instillation of chemotherapy after transurethral resection to transurethral resection alone in patients with stage pTa-pT1 urothelial carcinoma of the bladder. European Urology Supplements. 14(2). e939–e939a. 1 indexed citations

Xylinas, Évanguelos, Matthew Kent, Luis A. Kluth, et al.. (2013). Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder. British Journal of Cancer. 109(6). 1460–1466. 163 indexed citations

Chromecki, Thomas, Robert S. Svatek, S. Holmäng, et al.. (2011). Prognostic factors of cancer recurrence and progression in non-muscle-invasive urothelial carcinoma: A multicenter study of over 4,300 patients.. Journal of Clinical Oncology. 29(7_suppl). 249–249.

Jahnson, Staffan, et al.. (2011). 431 INITIAL BCG INSTILLATION IS UNDER-USED IN T1 BLADDER CANCER. European Urology Supplements. 10(2). 148–148. 1 indexed citations

Schumacher, Mary Catherine, et al.. (2009). 1009 TRANSURETHRAL RESECTION OF NON-MUSCLE-INVASIVE BLADDER TRANSITIONAL CELL CANCERS WITH OR WITHOUT 5-ALA UNDER VISIBLE AND FLUORESCENT LIGHT – MULTICENTER PHASE III CLINICAL TRIAL. European Urology Supplements. 8(4). 373–373. 4 indexed citations

Holmäng, S., et al.. (2008). A SINGLE INSTILLATION OF EPIRUBICIN AFTER TRANSURETHRAL RESECTION OF BLADDER TUMOURS RESULTS IN LESS SMALL- SIZED (UP TO 0.5 CM) RECURRENCES ONLY. European Urology Supplements. 7(3). 177–177.

Holmäng, S., et al.. (2004). Bacillus Calmette‐Guérin therapy in stage Ta/T1 bladder cancer: prognostic factors for time to recurrence and progression. British Journal of Urology. 93(7). 980–984. 56 indexed citations

Ryd, Walter, et al.. (2003). Cytopathological expression of different types of urothelial carcinoma in situ in urinary bladder washings. British Journal of Urology. 92(9). 906–910. 3 indexed citations

Holmäng, S., et al.. (2003). Four bladder tumor markers have a disappointingly low sensitivity for small size and low grade recurrence.. Urologic Oncology Seminars and Original Investigations. 21(2). 163–164. 12 indexed citations

10.

Holmäng, S., et al.. (2003). Stage ta-t1 bladder cancer: the relationship between findings at first followup cystoscopy and subsequent recurrence and progression.. Urologic Oncology Seminars and Original Investigations. 21(2). 163–163. 5 indexed citations

11.

Holmäng, S.. (2001). The Nested Variant of Transitional Cell Carcinoma - A Rare Neoplasm with Poor Prognosis. Scandinavian Journal of Urology and Nephrology. 35(2). 102–105. 64 indexed citations

12.

Boman, Hans, et al.. (2001). [When is it meaningful to investigate hematuria? Macroscopic hematuria--investigate always. Microscopic hematuria--symptoms and age decide].. PubMed. 98(48). 5498–500, 5503. 1 indexed citations

13.

Johansson, Sonny L., Göran Borghede, & S. Holmäng. (1999). MICROPAPILLARY BLADDER CARCINOMA: A CLINICOPATHOLOGICAL STUDY OF 20 CASES. The Journal of Urology. 161(6). 1798–1802. 153 indexed citations

14.

Johansson, Sonny L., Göran Borghede, & S. Holmäng. (1999). MICROPAPILLARY BLADDER CARCINOMA. The Journal of Urology. 1798–1802. 3 indexed citations

15.

Hedelin, Hans, S. Holmäng, & Lars-Gösta Wiman. (1997). [Outpatient treatment of bladder cancer--lower cost and satisfied patients].. PubMed. 112(2). 48–51. 4 indexed citations

16.

Holmäng, S., Frank Aldenborg, & Hans Hedelin. (1994). Extirpation and fulguration of multiple superficial bladder tumour recurrences under intravesical lignocaine anaesthesia. British Journal of Urology. 73(2). 177–180. 20 indexed citations

17.

Holmäng, S., et al.. (1994). Multiple bladder biopsies under intravesical lignocaine anaesthesia. British Journal of Urology. 73(2). 160–163. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact